TRIO Pharmaceuticals, Inc.

📍 San Diego, United States🗓 Founded 2018👥 9 employees💰 Last funded Aug 2024
Biotechnology Research🌐 triopharmaceuticals.com
Website LinkedIn
We are a cancer therapeutics company with a mission to improve efficacy, reduce toxicity and increase treatment affordability of cancer drugs. We are an experienced team in cancer drug discovery and development. Team members have invented and developed drugs that are approved for cancer treatment. Our approach to eradicating cancer is distinct from the current standard of care. Current approaches involve single agent single action drugs that either inhibit cancer cell growth or inhibit immunosuppression, and hence, they are ineffective. These drugs are combined in a bid to improve efficacy. But combination leads to toxicity, poor efficacy, and high cost. We are developing single agent dual action treatments inhibiting both cancer growth and immunosuppression. We are not targeting the immune checkpoint axis. Our approach will be effective for cancer patients that failed immune checkpoint treatments due to resistance or low expression of PD1, PDL1, CTLA4 etc..
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in TRIO Pharmaceuticals, Inc.?
TRIO Pharmaceuticals, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did TRIO Pharmaceuticals, Inc. last raise funding?
The most recent investment in TRIO Pharmaceuticals, Inc. recorded on gritt.io was in August 2024.
When was TRIO Pharmaceuticals, Inc. founded?
TRIO Pharmaceuticals, Inc. was founded in 2018.
What industry is TRIO Pharmaceuticals, Inc. in?
TRIO Pharmaceuticals, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is TRIO Pharmaceuticals, Inc. based?
TRIO Pharmaceuticals, Inc. is headquartered in San Diego, United States.